Kevin D. Brandt - 15 Aug 2021 Form 4 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Role
Chief Commercial Officer
Signature
/s/ Amy Culbert, attorney-in-fact
Issuer symbol
XTNT
Transactions as of
15 Aug 2021
Net transactions value
-$8,603
Form type
4
Filing time
17 Aug 2021, 17:32:15 UTC
Previous filing
13 Jul 2021
Next filing
17 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XTNT Common Stock, $0.000001 par value Award $0 +162,109 +100% $0.000000 323,661 15 Aug 2021 Direct F1, F2
transaction XTNT Common Stock, $0.000001 par value Tax liability $8,603 -7,169 -2.2% $1.20 316,492 15 Aug 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XTNT Stock Option (right to buy) Award $0 +199,519 $0.000000 199,519 15 Aug 2021 Common Stock 199,519 $1.27 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares will vest and be issued with respect to 40,527 shares on each of August 15, 2022, August 15, 2023 and August 15, 2024 and with respect to 40,528 shares on August 15, 2025 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan.
F2 Includes 251,081 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan.
F3 This option vests with respect to 49,879 shares on August 15, 2021 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc.